ES2199174T3 - Composicion que comprende un inhibidor de alfa-amilasa y al menos un compuesto fisiologicamente aceptable capaz de reducir la absorcion intestinal de "azucares rapidos". - Google Patents

Composicion que comprende un inhibidor de alfa-amilasa y al menos un compuesto fisiologicamente aceptable capaz de reducir la absorcion intestinal de "azucares rapidos".

Info

Publication number
ES2199174T3
ES2199174T3 ES00958855T ES00958855T ES2199174T3 ES 2199174 T3 ES2199174 T3 ES 2199174T3 ES 00958855 T ES00958855 T ES 00958855T ES 00958855 T ES00958855 T ES 00958855T ES 2199174 T3 ES2199174 T3 ES 2199174T3
Authority
ES
Spain
Prior art keywords
weight
composition
inhibitor
fat
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00958855T
Other languages
English (en)
Spanish (es)
Inventor
Nils Christian c/o Med-Eq AS MORTENSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MED-EQ AS
MED EQ AS
Original Assignee
MED-EQ AS
MED EQ AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MED-EQ AS, MED EQ AS filed Critical MED-EQ AS
Application granted granted Critical
Publication of ES2199174T3 publication Critical patent/ES2199174T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
ES00958855T 1999-09-08 2000-09-08 Composicion que comprende un inhibidor de alfa-amilasa y al menos un compuesto fisiologicamente aceptable capaz de reducir la absorcion intestinal de "azucares rapidos". Expired - Lifetime ES2199174T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9921229 1999-09-08
GBGB9921229.2A GB9921229D0 (en) 1999-09-08 1999-09-08 Compositions

Publications (1)

Publication Number Publication Date
ES2199174T3 true ES2199174T3 (es) 2004-02-16

Family

ID=10860574

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00958855T Expired - Lifetime ES2199174T3 (es) 1999-09-08 2000-09-08 Composicion que comprende un inhibidor de alfa-amilasa y al menos un compuesto fisiologicamente aceptable capaz de reducir la absorcion intestinal de "azucares rapidos".

Country Status (14)

Country Link
EP (1) EP1213972B1 (https=)
JP (1) JP2003508467A (https=)
KR (1) KR100594520B1 (https=)
AT (1) ATE238689T1 (https=)
AU (1) AU777044B2 (https=)
CA (1) CA2383720A1 (https=)
DE (1) DE60002484T2 (https=)
DK (1) DK1213972T3 (https=)
ES (1) ES2199174T3 (https=)
GB (2) GB9921229D0 (https=)
NO (1) NO314922B1 (https=)
NZ (1) NZ518167A (https=)
PT (1) PT1213972E (https=)
WO (1) WO2001017369A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217556B1 (en) 2000-12-23 2007-05-15 Pfizer Inc Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
US7601528B1 (en) 2000-12-23 2009-10-13 Elan Pharmaceuticals, Inc. Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US7384773B1 (en) 2001-05-10 2008-06-10 Pfizer Inc Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
US6797287B2 (en) 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
US7108869B2 (en) 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
ITMI20030391A1 (it) * 2003-03-04 2004-09-05 S I I T S R L Servizio Internaz Ionale Imballa Formulazioni anticarie a base di faseolamina.
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
JP5285852B2 (ja) * 2006-12-28 2013-09-11 株式会社ファンケル Ｄｆａｉｉｉの製造方法及びｄｆａｉｉｉ高含有植物エキス
US20100330137A1 (en) * 2008-03-10 2010-12-30 Mauro Mantovani High bioavailability formulation of mangosteen and manufacturing process thereof
CA2751227C (en) * 2009-02-02 2021-10-26 Laila Nutraceuticals Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
JP2011079752A (ja) * 2009-10-05 2011-04-21 Kracie Home Products Ltd 膵リパーゼ阻害剤並びにそれを含有する飲食品組成物及び医薬品組成物
CN103478738B (zh) * 2013-09-17 2016-02-10 深圳太太药业有限公司 一种具有减肥塑身及体重管理作用的组合物
CN106686988A (zh) * 2014-09-19 2017-05-17 雀巢产品技术援助有限公司 用于降低伴侣动物碳水化合物吸收的方法和配制物
CN106036342A (zh) * 2016-06-14 2016-10-26 安徽平唐微食疗科技有限公司 适合于糖尿病人群食用的膳食补充固体饮料及其制备方法
IT201700078389A1 (it) * 2017-07-13 2019-01-13 Mv Medical Solutions Composizione utile nella prevenzione o trattamento degli stati di malassorbimento secondari a chirurgia bariatrica in soggetti obesi.
AU2020281621B2 (en) * 2019-05-24 2025-09-11 Cosucra Groupe Warcoing S.A. Composition comprising inulin and protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
JP2757405B2 (ja) * 1988-12-09 1998-05-25 日清製粉株式会社 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤
US5612039A (en) * 1994-03-14 1997-03-18 Nini E. Policappelli Dietary supplement
WO2000043036A2 (en) * 1999-01-22 2000-07-27 Hunza Di Maria Carmela Marazzita S.A.S. Lipoprotein complexes and compositions containing them

Also Published As

Publication number Publication date
CA2383720A1 (en) 2001-03-15
DK1213972T3 (da) 2003-08-18
GB9921229D0 (en) 1999-11-10
EP1213972B1 (en) 2003-05-02
DE60002484D1 (de) 2003-06-05
PT1213972E (pt) 2003-09-30
ATE238689T1 (de) 2003-05-15
AU777044B2 (en) 2004-09-30
AU7026900A (en) 2001-04-10
EP1213972A1 (en) 2002-06-19
KR20020045605A (ko) 2002-06-19
NO314922B1 (no) 2003-06-16
GB2364498A (en) 2002-01-30
KR100594520B1 (ko) 2006-07-19
NO20021160L (no) 2002-03-27
NO20021160D0 (no) 2002-03-08
NZ518167A (en) 2003-03-28
DE60002484T2 (de) 2004-03-18
GB0127158D0 (en) 2002-01-02
JP2003508467A (ja) 2003-03-04
WO2001017369A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
ES2199174T3 (es) Composicion que comprende un inhibidor de alfa-amilasa y al menos un compuesto fisiologicamente aceptable capaz de reducir la absorcion intestinal de "azucares rapidos".
US8372447B2 (en) Compositions and methods for promoting weight loss and increasing energy
AU2009252911B2 (en) Composition comprising 1, 3 /1, 6 beta glucan for reducing weight
ES2274246T3 (es) Utilizacion de pululano como un carbohidrato digerido lentamente.
ES2682940T3 (es) Composición que comprende ocra para su uso en reducir la absorción de grasa alimenticia
CN105380962B (zh) 一种降尿酸组合物及其制剂
WO2008034316A1 (en) Compound preparation capable of reducing oxidative stress rapidly and the preparative method thereof
US20110142971A1 (en) Use of an onion extract for making a composition to control weight gain
KR20170142756A (ko) 굼벵이를 포함하는 간 및 혈액순환 개선용 조성물 및 그 제조방법
WO2008096171A2 (en) Natural laxative composition comprising prunes, raisins, apricots, dates, figs, olive oil, senna and honey
WO2021028743A1 (en) Nutritional compositions for management of irritable bowel disease/syndrome and improve gut health
KR101824016B1 (ko) 포공영, 어성초, 금은화, 몰약, 위령선, 택사, 목통, 차전자, 유근피, 죽엽, 결명자, 당귀, 작약 및 감초의 혼합추출물을 포함하는 관절염의 예방 또는 치료용 약학적 조성물
ES2266494T3 (es) Formulacion combinado para el tratamiento de la de la diabetes mellitas.
US20090208588A1 (en) GERD carbohydrate compositions
KR0137897B1 (ko) 두충엽을 주원료로 함유한 건강식품 조성물
US20070167395A1 (en) Compositions and methods for treating diabetes
CN110063977B (zh) 一种党参、沙棘复合冲剂及其应用
US20050003027A1 (en) Chemical composition and method to bind fat, enhance metabolization, and aid digestion
CN115956675B (zh) 一种辅助保护胃粘膜组合物作为功效成分在制备保健食品中的用途
KR20150044014A (ko) 소화흡수를 억제하는 항비만용 추출물 및 그 제조방법
US20040018990A1 (en) Treatment of obesity
KR102862135B1 (ko) 다래 분말을 유효성분으로 함유하는 변비개선용 조성물
JPH0669352B2 (ja) 体質改善食品
JPH06345660A (ja) ナトリウム吸収阻害剤、ナトリウム吸収阻害飲食物および動物用飲食物
KR102198502B1 (ko) 인체의 림프순환 개선을 위한 식품 조성물